The role and application of transcriptional repressors in cancer treatment.
- Published in:
- Archives of Pharmacal Research, 2023, v. 46, n. 1, p. 1, doi. 10.1007/s12272-023-01427-4
- By:
- Publication type:
- Article
Works matching IS 02536269 AND DT 2023 AND VI 46 AND IP 1
Results: 5
1
2
MEKs/ERKs-mediated FBXO1/E2Fs interaction interference modulates G<sub>1</sub>/S cell cycle transition and cancer cell proliferation.
- Published in:
- Archives of Pharmacal Research, 2023, v. 46, n. 1, p. 44, doi. 10.1007/s12272-023-01426-5
- By:
- Publication type:
- Article
3
Recent advances in selective and targeted drug/gene delivery systems using cell-penetrating peptides.
- Published in:
- Archives of Pharmacal Research, 2023, v. 46, n. 1, p. 18, doi. 10.1007/s12272-022-01425-y
- By:
- Publication type:
- Article
4
Isolation, structure elucidation, total synthesis, and biosynthesis of dermazolium A, an antibacterial imidazolium metabolite of a vaginal bacterium Dermabacter vaginalis.
- Published in:
- Archives of Pharmacal Research, 2023, v. 46, n. 1, p. 35, doi. 10.1007/s12272-022-01424-z
- By:
- Publication type:
- Article
5
Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone.
- Published in:
- Archives of Pharmacal Research, 2023, v. 46, n. 1, p. 59, doi. 10.1007/s12272-022-01422-1
- By:
- Publication type:
- Article